Compare CMTL & QTRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | CMTL | QTRX |
|---|---|---|
| Founded | 1967 | 2007 |
| Country | United States | United States |
| Employees | 1385 | N/A |
| Industry | Radio And Television Broadcasting And Communications Equipment | Biotechnology: Laboratory Analytical Instruments |
| Sector | Technology | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 133.7M | 160.0M |
| IPO Year | 2024 | 2017 |
| Metric | CMTL | QTRX |
|---|---|---|
| Price | $1.76 | $2.57 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 1 | 2 |
| Target Price | $6.00 | $6.00 |
| AVG Volume (30 Days) | 350.7K | ★ 742.3K |
| Earning Date | 06-08-2026 | 05-06-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $499,528,000.00 | $37,632,000.00 |
| Revenue This Year | N/A | $25.49 |
| Revenue Next Year | $4.56 | $10.04 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | ★ 64.52 |
| 52 Week Low | $1.59 | $2.15 |
| 52 Week High | $6.21 | $8.77 |
| Indicator | CMTL | QTRX |
|---|---|---|
| Relative Strength Index (RSI) | 40.18 | 36.05 |
| Support Level | N/A | $2.40 |
| Resistance Level | $1.89 | $3.85 |
| Average True Range (ATR) | 0.09 | 0.25 |
| MACD | 0.06 | -0.12 |
| Stochastic Oscillator | 66.67 | 24.34 |
Comtech Telecommunications Corp is a provider of communications technology and solutions. It operates in two reportable business segments: Satellite and Space Communications and Allerium. The company's Satellite and Space Communications segment, which generates maximum revenue, is organized into four technology areas: satellite modem and amplifier technologies, troposcatter technologies, cybersecurity training, and space components. This segment designs and manufactures modems, amplifiers, traveling wave tube amplifiers, frequency converters, and offers other associated software and services. The Allerium segment provides next-generation 911 (NG-911) infrastructure and solutions for state and local governments and carriers. Geographically, the company derives its key revenue from the USA.
Quanterix Corp is a life sciences company accelerating biomarker breakthroughs from discovery to diagnostics using ultra-sensitive translational research and spatial biology instruments, consumables, and services. The company sells proprietary instruments and related consumables to research laboratories, contract research organizations (CROs), academic institutions, and bio-pharmaceutical companies, and provides contract research services and clinical laboratory testing services, including four Laboratory Developed Tests (LDTs), through its Accelerator Laboratory. Its products include Simoa, Assay Kits, LDTs & Assay Services, Simoa p-Tau 217, Simoa NfL LDT, Simoa p-Tau 181 LDT, and SP-X Imaging and Analysis System. Geographically, it operates in North America, EMEA, and the Asia Pacific.